David Peltier

 

David Peltier joined TheStreet as a research associate in August 2001, and writes TheStreet Stocks Under $10. Before that, Peltier was an analyst for Individual Investor magazine and the publication's Web site. His market interests include small-caps, technology and retail stocks. He has appeared on NPR, NBR and WNYW-TV.

Peltier received his bachelor's degree cum laude in finance and international business from New York University.

 

----------

 

A Note From David: My name is David Peltier. I manage a much-followed portfolio for TheStreet called Stocks Under $10 -- the unique investment service that alerts you to what I believe are deeply undervalued stocks with tremendous growth potential.

 

I've made it my life's work to help investors like you build lasting wealth by investing in only the very best small company stocks.

 

Because it's these little-known companies, which are overlooked by much of Wall Street, that could break out and double or even triple your money!

 

Start Your 14-Day Free Trial of Stocks Under $10.

 


Recent Articles By The Author

Apple Lawsuit Weighs on Qualcomm

QCOM assails claims of AAPL, FTC.

Adding to TherapeuticsMD on Weakness

We maintain our $12.50 price target on this stock.

Stocks Under $10 Portfolio: Consumer Staples Overbought

Stocks Under $10 Portfolio: Consumer Staples Overbought

This week we'll get regional economic and housing data, a GDP report plus fourth-quarter earnings.

Stocks Under $10 Weekly Summary

We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.

GE Still Attractive, Despite Revenue Miss

The company has room to raise the dividend later this year.